Kirby Co. (NYSE: KEX), Galectin Therapeutics (OTC: GALT), Goodrich Petroleum Co. (NYSE: GDP), Gen-Probe Incorporated (NASDAQ: GPRO) and Groupon (NASDAQ: GRPN) getting new coverage from analysts.
Global Hunter Securities initiated coverage on Galectin Therapeutics (GALT). They placed a “Speculative Buy” rating and a price target of $3.00 on the company.
Global Hunter Securities initiated coverage on Goodrich Petroleum Co. (GDP). They placed a “Neutral” rating on the company.
Deutsche Bank (NYSE:DB) initiated coverage on Gen-Probe Incorporated (GPRO). They placed a “Buy” rating and a price target of $70.50 on the company.
Stifel Nicolaus initiated coverage on Groupon (GRPN). They placed a “Hold” rating on the company.
Evercore Partners initiated coverage on Kirby Co. (KEX). They placed an “Overweight” rating on the company.
No comments:
Post a Comment